Textual research on Bungarus Parvus.
10.19540/j.cnki.cjcmm.20230708.101
- Author:
Ting-Fen WU
1
;
Jing DENG
1
;
Xi WANG
1
;
Hong-Qiong LIU
2
;
Yun-Xia TENG
2
;
Zhi-Guo MA
1
;
Meng-Hua WU
1
;
Wei-Zhong HUANG
2
;
Hui CAO
1
;
Ying ZHANG
1
Author Information
1. Guangdong Provincial Key Laboratory of Traditional Chinese Medicine Informatization, National Engineering Research Center for Modernization of Traditional Chinese Medicine, Research Center for Traditional Chinese Medicine of Lingnan(Southern China), Lingnan Resources Branch, College of Pharmacy, Jinan University Guangzhou 510632, China.
2. Guangdong Luofushan Sinopharm Co., Ltd. Huizhou 516133, China.
- Publication Type:Journal Article
- Keywords:
Bungarus Parvus;
Bungarus multicinctus;
textual research
- MeSH:
Animals;
Bungarus;
Snakes;
China;
Medicine, Chinese Traditional;
Drugs, Chinese Herbal
- From:
China Journal of Chinese Materia Medica
2023;48(22):6234-6248
- CountryChina
- Language:Chinese
-
Abstract:
Bungarus Parvus, a precious animal Chinese medicinal material used in clinical practice, is believed to be first recorded in Ying Pian Xin Can published in 1936. This study was carried out to analyze the names, geographical distribution, morphological characteristics, ecological habits, poisonousness, and medicinal parts by consulting ancient Chinese medical books and local chronicles, Chinese Pharmacopeia, different processing standards of trditional Chinese medicine(TCM) decoction pieces, and modern literatures. The results showed that the earliest medicinal record of Bungarus Parvus was traced to 1894. In 1930, this medicinal material was used in the formulation of Annao Pills. The original animal, Bungarus multicinctus, was recorded by the name of "Bojijia" in 1521. The morphological characteristics, ecological habits, and poisonousness of the original animal are the same in ancient and modern records. The geographical distribution is similar between the ancient records and modern documents such as China Medicinal Animal Fauna. The dried body of young B. multicinctus is used as Bungarus Parvus, which lack detailed references. As a matter of fact, it is still inconclusive whether there are differences between young snakes and adult snakes in terms of active ingredients, pharmacological effects, and clinical applications. This study clarified the medicinal history and present situation of Bungarus Parvus. On the basis of the results, it is suggested that systematic comparison on young and adult B. multicinctus should be carried out to provide references for revising the medicinal parts of B. multicinctus.
